Tenofovir Df + Emtricitabine + Elvitegravir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Oral tablet (film-coated)
Available Strengths: Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg
Reference Brands: Stribild (US & EU)
Category: Anti Viral
Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat is available in Oral tablet (film-coated) and strengths such as Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Tenofovir Disoproxil Fumarate (TDF) + Emtricitabine + Elvitegravir + Cobicistat, marketed as Stribild, is a complete, once-daily, single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults and adolescents. This fixed-dose combination includes an integrase inhibitor (Elvitegravir), two NRTIs (TDF and Emtricitabine), and a pharmacokinetic booster (Cobicistat). Approved by the US FDA and EMA, Stribild offers strong viral suppression and improved patient adherence by reducing pill burden. It must be taken with food to ensure optimal absorption. Stribild is widely used in global HIV programs, though newer TAF-based regimens like Genvoya offer improved renal and bone safety.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Zanamivir
Strength:
5 mg/blister
Form: Inhalation powder
Reference Brands: Relenza(EU & US)
View Details
Oseltamivir Phosphate Capsule
Strength:
Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)
Form: Capsules and Oral solution
Reference Brands: Tamiflu(EU & US)
View Details
Amantadine
Strength:
Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg
Form: Tablet; Capsule; Oral Solution and ER Capsule
Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)
View Details
Glecaprevir + Pibrentasvir
Strength:
Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
